Published in Obesity and Diabetes Week, February 10th, 2003
The breakthrough has the potential to lead to novel treatments for diabetics and is aimed at reducing or eliminating the effects of a disease that affects about 16 million Americans.
Research results posted on the Journal of Biological Chemistry's web site at www.jbc.org show that a saturated fat metabolite called ceramide contributes to the development of insulin resistance in cultured cell experiments. Furthermore, the lab studies indicate that excess accumulation of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.